NEW YORK (GenomeWeb News) – Abraxis BioScience has awarded the John Wayne Cancer Institute at Saint John's Health Center in Santa Monica, Calif., a $1 million grant to search for genes and proteins that can serve as biomarkers for solid-tumor cancers.

The funding was awarded to John Wayne's Department of Molecular Oncology, directed by Dave Hoon. The research is designed to help develop new biomarker-specific blood tests for detecting cancer, the cancer institute said in a statement Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.